Countryfocus: Healthcare, Regulatory and Reimbursement Landscape - China

REF ER EN CE CO DE GDH C0052CH R | PU BLIC AT IO N D AT E JAN U ARY 2016

CountryFocus: Healthcare, Regulatory and

Reimbursement Landscape - China

Channel sales partner

China's Medical Device Market Will Burgeon Beyond $50 Billion by 2020

Medical Device Market, China, Revenue ($bn), 2008–2020

60

50

Revenue ($bn)

40

30

20

10

0

2008

2014

2017

2020

Source: GlobalData, Medical eTrack [Accessed on September 16, 2015]

The Chinese medical device market is set to rise from $27.7 billion in 2014 to an

estimated $50.8 billion by 2020, expanding at a strong Compound Annual Growth

Rate (CAGR) of 10.6%. This substantial increase will be driven by a number of

factors, including the increasing prevalence of metabolic syndromes and chronic

diseases, an aging population, as well as government investment. These factors are

all linked, as an aging population will lead to increased incidences of chronic

diseases such as respiratory diseases, cancers and cardiovascular disease. This will

provide medical device manufacturers with opportunities for growth. The leading

device companies in China who will benefit are Siemens Healthcare, GE Healthcare,

Philips Healthcare, Medtronic and Roche. The dominant player in terms of revenue

in China is Siemens, which has a best-in-class portfolio of ultrasound and medical

imaging solutions.

click to purchase - http://www.aarkstore.com/pharmaceuticals-healthcare/109491/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.